SRDX vs. OFIX, ANGO, ARAY, CTSO, ATRC, ATEC, BVS, PLSE, IRMD, and OSUR
Should you be buying Surmodics stock or one of its competitors? The main competitors of Surmodics include Orthofix Medical (OFIX), AngioDynamics (ANGO), Accuray (ARAY), Cytosorbents (CTSO), AtriCure (ATRC), Alphatec (ATEC), Bioventus (BVS), Pulse Biosciences (PLSE), Iradimed (IRMD), and OraSure Technologies (OSUR). These companies are all part of the "surgical & medical instruments" industry.
Surmodics (NASDAQ:SRDX) and Orthofix Medical (NASDAQ:OFIX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, risk, valuation, profitability, media sentiment, analyst recommendations, earnings, institutional ownership and dividends.
Surmodics has higher earnings, but lower revenue than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than Surmodics, indicating that it is currently the more affordable of the two stocks.
Orthofix Medical received 74 more outperform votes than Surmodics when rated by MarketBeat users. However, 67.13% of users gave Surmodics an outperform vote while only 61.80% of users gave Orthofix Medical an outperform vote.
Surmodics has a beta of 1.04, suggesting that its share price is 4% more volatile than the S&P 500. Comparatively, Orthofix Medical has a beta of 1.06, suggesting that its share price is 6% more volatile than the S&P 500.
Surmodics presently has a consensus target price of $57.00, indicating a potential upside of 64.64%. Orthofix Medical has a consensus target price of $18.00, indicating a potential upside of 20.00%. Given Surmodics' stronger consensus rating and higher possible upside, analysts plainly believe Surmodics is more favorable than Orthofix Medical.
Surmodics has a net margin of 9.44% compared to Orthofix Medical's net margin of -16.64%. Surmodics' return on equity of 13.30% beat Orthofix Medical's return on equity.
In the previous week, Orthofix Medical had 3 more articles in the media than Surmodics. MarketBeat recorded 4 mentions for Orthofix Medical and 1 mentions for Surmodics. Orthofix Medical's average media sentiment score of 0.34 beat Surmodics' score of 0.00 indicating that Orthofix Medical is being referred to more favorably in the news media.
96.6% of Surmodics shares are owned by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are owned by institutional investors. 8.9% of Surmodics shares are owned by company insiders. Comparatively, 4.7% of Orthofix Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Summary
Surmodics beats Orthofix Medical on 12 of the 17 factors compared between the two stocks.
Get Surmodics News Delivered to You Automatically
Sign up to receive the latest news and ratings for SRDX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SRDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Surmodics Competitors List
Related Companies and Tools
